Solid-state properties of Nifurtimox. Preparation, analytical characterization, and stability of an amorphous phase-Reference-Cited by-同舟云学术

Solid-state properties of Nifurtimox. Preparation, analytical characterization, and stability of an amorphous phase

Published:2023-03 Issue: Volume:184 Page:25-35
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Moroni Aldana B.^ORCID,Mayoral Elena Perez,Lionello Diego F.^ORCID,Vega Daniel R.^ORCID,Kaufman Teodoro S.^ORCID,Calvo Natalia.L.^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference70 articles.

1. H. Herlinger, K.-H. Mayer, S. Petersen, M. Bock, Verfahren zur Herstellung von 5-Nitro-furfuryliden-(2)-iminoderivaten. Patent DE 1170957, 1964 to Bayer A.G.

2. H. Herlinger, K.-H. Mayer, S. Petersen, M. Bock, Novel 5-nitro-furfurylidene-(2)-derivatives and process for producing the same. Patent US 3262930, 1966 to Bayer A.G.

3. World Health Organization. (2021). World Health Organization model list of essential medicines: 22nd list (2021). World Health Organization. Available at: https://apps.who.int/iris/handle/10665/345533 (accessed 23.12.22).

4. The future of Chagas disease control;Schofield;Trends Parasitol.,2006

5. Update on nifurtimox for treatment of Chagas disease;Thakare;Drugs Today,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conformational analysis and spectroscopic properties of antichagasic nifurtimox;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-08

2. Preparation and characterization of new salts of tioconazole. Comparison of their dissolution performance;International Journal of Pharmaceutics;2024-03

3. Melt crystallization and thermal degradation profile of the antichagasic drug nifurtimox;Journal of Pharmaceutical and Biomedical Analysis;2024-02

4. Selected Aspects of the Analytical and Pharmaceutical Profiles of Nifurtimox;Journal of Pharmaceutical Sciences;2023-06